Market Tracker

07/28 1:44pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.41
Delayed Data
As of 1:29pm ET
 +0.27 / +2.66%
Today’s Change
5.53
Today|||52-Week Range
13.84
-7.88%
Year-to-Date

Today’s Trading

Previous close10.14
Today’s open10.24
Day’s range10.12 - 10.45
Volume656,134
Average volume (3 months)1,232,454
Market cap$1.1B
Dividend yield--
Data as of 1:29pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-40.62%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RPTPRaptor Pharmaceutica...+0.24+1.74%
HRTXHeron Therapeutics I...+1.68+5.20%
RGENRepligen Corp+0.90+2.49%
MGNXMacroGenics Inc+1.24+3.49%
Data as of 1:44pm ET, 07/28/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts